These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 32665936

  • 1. COVID-19 in a Patient with Chronic Lymphocytic Leukaemia with Pseudohypoxemia.
    Alves Barbosa O, Guimarães Andrade T, de Almeida Sousa MD, Correia JW.
    Eur J Case Rep Intern Med; 2020; 7(7):001763. PubMed ID: 32665936
    [Abstract] [Full Text] [Related]

  • 2. Correlation of pseudohypoxemia and leukocytosis in chronic lymphocytic leukemia.
    Gorski TF, Ajemian M, Hussain E, Talhouk A, Ruskin G, Hanna A, Jacobs M.
    South Med J; 1999 Aug; 92(8):817-9. PubMed ID: 10456725
    [Abstract] [Full Text] [Related]

  • 3. COVID-19-Induced Hyperleucocytosis in Chronic Lymphocytic Leukaemia.
    Singh B, Ayad S, Kaur P, Reid RJ, Gupta S, Maroules M.
    Eur J Case Rep Intern Med; 2021 Aug; 8(3):002348. PubMed ID: 33869094
    [Abstract] [Full Text] [Related]

  • 4. Newly Diagnosed Chronic Lymphocytic Leukemia During Symptomatic COVID-19: Two Cases.
    Papp E, Tasnády S, Tisza K, Király Á, Bekő G.
    EJIFCC; 2022 Aug; 33(2):187-193. PubMed ID: 36313909
    [Abstract] [Full Text] [Related]

  • 5. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL, Figgitt DP.
    Drugs; 2003 Aug; 63(8):803-43. PubMed ID: 12662126
    [Abstract] [Full Text] [Related]

  • 6. Chronic Lymphocytic Leukemia Concomitant with COVID 19: A Case Report.
    Ali E, Badawi M, Abdelmahmuod E, Kohla S, Yassin MA.
    Am J Case Rep; 2020 Oct 24; 21():e926062. PubMed ID: 33098641
    [Abstract] [Full Text] [Related]

  • 7. Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic.
    Di Ciaccio P, McCaughan G, Trotman J, Ho PJ, Cheah CY, Gangatharan S, Wight J, Ku M, Quach H, Gasiorowski R, Polizzotto MN, Prince HM, Mulligan S, Tam CS, Gregory G, Hapgood G, Spencer A, Dickinson M, Latimer M, Johnston A, Armytage T, Lee C, Cochrane T, Berkhahn L, Weinkove R, Doocey R, Harrison SJ, Webber N, Lee HP, Chapman S, Campbell BA, Gibbs SDJ, Hamad N.
    Intern Med J; 2020 Jun 24; 50(6):667-679. PubMed ID: 32415723
    [Abstract] [Full Text] [Related]

  • 8. SARS-CoV-2 infection among patients with haematological disorders: Severity and one-month outcome in 66 Danish patients in a nationwide cohort study.
    Glenthøj A, Jakobsen LH, Sengeløv H, Ahmad SA, Qvist K, Rewes A, Poulsen CB, Overgaard UM, Mølle I, Severinsen MT, Strandholdt CN, Maibom J, Kodahl AR, Ryg J, Ravn P, Johansen IS, Helsø SN, Jensen-Fangel S, Kisielewicz J, Wiese L, Helleberg M, Kirk O, Clausen MR, Frederiksen H.
    Eur J Haematol; 2021 Jan 24; 106(1):72-81. PubMed ID: 32939853
    [Abstract] [Full Text] [Related]

  • 9. Low Humoral Immune Response and Ineffective Clearance of SARS-Cov-2 in a COVID-19 Patient With CLL During a 69-Day Follow-Up.
    Ye X, Xiao X, Li B, Zhu W, Li Y, Wu J, Huang X, Jin J, Chen D, Jin J, Huang J.
    Front Oncol; 2020 Jan 24; 10():1272. PubMed ID: 32719750
    [Abstract] [Full Text] [Related]

  • 10. Challenges in Diagnosis and Clinical Management of COVID-19 in Patient with B-Cell Chronic Lymphocytic Leukemia (CLL): Report of One Case.
    Visco V, Lippi ME, Salerno G, Licata MAVAC, de Dominicis C, Antolino G, La Verde G, Santino I, Simmaco M, Sciacchitano S.
    Hematol Rep; 2022 Mar 17; 14(1):31-37. PubMed ID: 35323177
    [Abstract] [Full Text] [Related]

  • 11. Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignancies.
    Sanchez-Pina JM, Rodríguez Rodriguez M, Castro Quismondo N, Gil Manso R, Colmenares R, Gil Alos D, Paciello ML, Zafra D, Garcia-Sanchez C, Villegas C, Cuellar C, Carreño-Tarragona G, Zamanillo I, Poza M, Iñiguez R, Gutierrez X, Alonso R, Rodríguez A, Folgueira MD, Delgado R, Ferrari JM, Lizasoain M, Aguado JM, Ayala R, Martinez-Lopez J, Calbacho M.
    Eur J Haematol; 2020 Nov 17; 105(5):597-607. PubMed ID: 32710500
    [Abstract] [Full Text] [Related]

  • 12. Concurrence of chronic lymphocytic leukaemia/small lymphocytic lymphoma and acute myeloid leukaemia in a bone marrow biopsy.
    Licci S.
    Pol J Pathol; 2020 Nov 17; 71(3):285-287. PubMed ID: 33112122
    [Abstract] [Full Text] [Related]

  • 13. Clinical characteristics of four cancer patients with SARS-CoV-2 infection in Wuhan, China.
    Song SH, Chen TL, Deng LP, Zhang YX, Mo PZ, Gao SC, Hu WJ, Xiong Y, Ma ZY.
    Infect Dis Poverty; 2020 Jul 02; 9(1):82. PubMed ID: 32616030
    [Abstract] [Full Text] [Related]

  • 14. Pseudohypoxemia From Leukocyte Larceny in a Patient With Chronic Myelogenous Leukemia.
    Mirzai S, Andreae M, Puttarajappa C.
    Cureus; 2022 Jan 02; 14(1):e21405. PubMed ID: 35198312
    [Abstract] [Full Text] [Related]

  • 15. Emergence of Chronic Lymphocytic Leukemia During Admission for COVID-19: Cause or Coincidence?
    Saluja P, Gautam N, Amisha F, Safar M, Bartter T.
    Cureus; 2022 Mar 02; 14(3):e23470. PubMed ID: 35494899
    [Abstract] [Full Text] [Related]

  • 16. Outcome of SARS-CoV-2-Infected Polish Patients with Chronic Lymphocytic Leukemia.
    Puła B, Pruszczyk K, Pietrusza E, Morawska M, Piszczek W, Kalicińska E, Szeremet A, Tryc-Szponder J, Wąsik-Szczepanek E, Drozd-Sokołowska J, Krzemień H, Rejus A, Gajewska M, Wiśniewski K, Wysocki M, Majeranowski A, Paszkiewicz-Kozik E, Steckiewicz P, Szukalski Ł, Bołkun Ł, Długosz-Danecka M, Giannopoulos K, Jamroziak K, Lech-Marańda E, Hus I.
    Cancers (Basel); 2022 Jan 22; 14(3):. PubMed ID: 35158826
    [Abstract] [Full Text] [Related]

  • 17. COVID-19 vaccine failure in chronic lymphocytic leukaemia and monoclonal B-lymphocytosis; humoural and cellular immunity.
    Shen Y, Freeman JA, Holland J, Solterbeck A, Naidu K, Soosapilla A, Downe P, Tang C, Kerridge I, Wallman L, Van Bilsen N, Milogiannakis V, Akerman A, Martins Costa Gomes G, Sandgren K, Cunningham AL, Turville S, Mulligan SP.
    Br J Haematol; 2022 Apr 22; 197(1):41-51. PubMed ID: 34962656
    [Abstract] [Full Text] [Related]

  • 18. An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data.
    International CLL-IPI working group.
    Lancet Oncol; 2016 Jun 22; 17(6):779-790. PubMed ID: 27185642
    [Abstract] [Full Text] [Related]

  • 19. [Prognostic value of absolute monocyte count in chronic lymphocytic leukaemia].
    Szerafin L, Jakó J, Riskó F.
    Orv Hetil; 2015 Apr 22; 156(15):592-7. PubMed ID: 25845318
    [Abstract] [Full Text] [Related]

  • 20. Ibrutinib-associated invasive fungal diseases in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: An observational study.
    Ruchlemer R, Ben-Ami R, Bar-Meir M, Brown JR, Malphettes M, Mous R, Tonino SH, Soussain C, Barzic N, Messina JA, Jain P, Cohen R, Hill B, Mulligan SP, Nijland M, Herishanu Y, Benjamini O, Tadmor T, Okamoto K, Arthurs B, Gottesman B, Kater AP, Talha M, Eichhorst B, Korem M, Bogot N, De Boer F, Rowe JM, Lachish T.
    Mycoses; 2019 Dec 22; 62(12):1140-1147. PubMed ID: 31520441
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.